标题
Biomarker research in prostate cancer—towards utility, not futility
作者
关键词
-
出版物
Nature Reviews Urology
Volume 8, Issue 3, Pages 131-138
出版商
Springer Nature
发表日期
2011-03-11
DOI
10.1038/nrurol.2011.11
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Final outcomes of patients with low-risk prostate cancer suitable for active surveillance but treated surgically
- (2009) Mark Louie-Johnsun et al. BJU INTERNATIONAL
- Locally advanced prostate cancer: the role of surgical management
- (2009) Kelly L. Stratton et al. BJU INTERNATIONAL
- Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men
- (2009) Sang E. Lee et al. BJU INTERNATIONAL
- Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy
- (2009) Morgan Rouprêt et al. BJU INTERNATIONAL
- Radical retropubic prostatectomy for prostate cancer with microscopic bladder neck involvement: survival and prognostic implications
- (2009) Donata Villari et al. BJU INTERNATIONAL
- Pelvic Lymph Node Dissection in Prostate Cancer
- (2009) Alberto Briganti et al. EUROPEAN UROLOGY
- Eleven-Year Outcome of Patients with Prostate Cancers Diagnosed During Screening After Initial Negative Sextant Biopsies
- (2009) Fritz H. Schröder et al. EUROPEAN UROLOGY
- The Epstein Criteria Predict for Organ-Confined But Not Insignificant Disease and a High Likelihood of Cure at Radical Prostatectomy
- (2009) Michael C. Lee et al. EUROPEAN UROLOGY
- Validation of Epstein criteria of insignificant prostate cancer in Middle East patients
- (2009) Ihab A. Hekal et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Novel predictive tools for Irish radical prostatectomy pathological outcomes: development and validation
- (2009) D. M. Fanning et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?
- (2009) Jennifer R. Stark et al. JOURNAL OF CLINICAL ONCOLOGY
- Lymph node assessment and lymphadenectomy in prostate cancer
- (2009) Michael Ordon et al. JOURNAL OF SURGICAL ONCOLOGY
- Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based Cohort
- (2009) Jonathan L. Wright et al. JOURNAL OF UROLOGY
- Validation of the Partin Nomogram for Prostate Cancer in a National Sample
- (2009) James B. Yu et al. JOURNAL OF UROLOGY
- An Update of the Gleason Grading System
- (2009) Jonathan I. Epstein JOURNAL OF UROLOGY
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens
- (2008) Hiroji Uemura et al. BJU INTERNATIONAL
- An updated catalog of prostate cancer predictive tools
- (2008) Shahrokh F. Shariat et al. CANCER
- Active surveillance for early-stage prostate cancer
- (2008) Marc A. Dall'Era et al. CANCER
- The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis
- (2008) A.M. Hövels et al. CLINICAL RADIOLOGY
- Partin Tables cannot accurately predict the pathological stage at radical prostatectomy
- (2008) N. Bhojani et al. EJSO
- External Validation of the Updated Partin Tables in a Cohort of French and Italian Men
- (2008) Naeem Bhojani et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer
- (2008) C. Gosselaar et al. PROSTATE
- Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
- (2007) Claudio Jeldres et al. EUROPEAN UROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started